• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Research Brief on Methyl 4,6-dimethylpicolinate (CAS: 69971-38-6): Recent Advances and Applications in Chemical Biology and Pharmaceutical Sciences

Methyl 4,6-dimethylpicolinate (CAS: 69971-38-6) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals and agrochemicals. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential as a building block for drug discovery. This research brief aims to summarize the latest findings related to this compound, focusing on its synthetic applications, biological activities, and emerging roles in targeted therapies.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of Methyl 4,6-dimethylpicolinate in the synthesis of novel kinase inhibitors. The compound's pyridine core structure was modified to develop selective inhibitors for tyrosine kinases involved in cancer progression. Researchers reported improved pharmacokinetic properties and reduced off-target effects compared to earlier generations of inhibitors, suggesting its potential as a scaffold for next-generation anticancer agents.

In the field of antimicrobial research, Methyl 4,6-dimethylpicolinate has shown promise as a precursor for quorum-sensing inhibitors. A recent ACS Infectious Diseases publication (2024) described its incorporation into small molecules that disrupt bacterial communication pathways, effectively reducing virulence in multidrug-resistant pathogens without inducing strong selective pressure for resistance development. This approach represents a promising alternative to traditional antibiotics in the era of antimicrobial resistance.

From a synthetic chemistry perspective, advances in catalytic systems have improved the efficiency of Methyl 4,6-dimethylpicolinate production. A 2024 Organic Process Research & Development paper detailed a continuous-flow process that achieves >90% yield with minimal waste generation, addressing both economic and environmental concerns in industrial-scale manufacturing. This technological advancement is particularly relevant given the compound's growing importance in pharmaceutical supply chains.

Emerging applications in radiopharmaceuticals have also been reported. Researchers at several academic medical centers are exploring 11C-labeled derivatives of Methyl 4,6-dimethylpicolinate for positron emission tomography (PET) imaging of neurological disorders. Preliminary results suggest these tracers may provide superior imaging characteristics for amyloid plaques compared to currently available diagnostic agents.

The safety profile of Methyl 4,6-dimethylpicolinate continues to be evaluated through comprehensive toxicological studies. Recent in vitro and in vivo assessments (2023-2024) indicate favorable characteristics at therapeutic doses, though researchers emphasize the need for further investigation of long-term exposure effects. These findings support the compound's potential for clinical translation while highlighting areas requiring additional study.

Looking forward, the versatility of Methyl 4,6-dimethylpicolinate positions it as a valuable tool in chemical biology and drug discovery. Its applications span from traditional small-molecule therapeutics to cutting-edge areas like targeted protein degradation and covalent inhibitor design. As synthetic methodologies advance and our understanding of structure-activity relationships deepens, this compound is likely to play an increasingly important role in addressing unmet medical needs across multiple therapeutic areas.

• 317335-15-2(methyl 4-(hydroxymethyl)pyridine-2-carboxylate)
• 5453-67-8(2,6-dimethyl pyridine-2,6-dicarboxylate)
• 69950-65-8(Methyl 6-formylpyridine-2-carboxylate)
• 39977-44-1(methyl 6-(hydroxymethyl)pyridine-2-carboxylate)
• 41438-38-4(2,4-diethyl pyridine-2,4-dicarboxylate)
• 2459-07-6(methyl pyridine-2-carboxylate)
• 7170-36-7(6-(methoxycarbonyl)pyridine-2-carboxylic acid)
• 13602-11-4(Methyl 6-methylpyridine-2-carboxylate)
• 24195-03-7(4-(Methoxycarbonyl)picolinic acid)
• 25658-36-0(Dimethyl pyridine-2,4-dicarboxylate)